Coagulopathy in CAR‐T: Critical concern or mere blip?

Abstract

Despite Peng and colleagues providing an extensive review of the clinical and laboratory aspects of CAR‐T‐associated coagulopathy, the current literature often lacks specificity in nomenclature and gradings, and the clinical implications of coagulopathy may remain unclear. Clear recommendations on stratification and prophylaxis are still required to standardize the clinical approach to this topic.Commentary on: Peng et al. Coagulation abnormalities associated with CAR‐T therapy in hematological malignancies: A review. Br J Haematol 2024;205:420‐428.